HPM Partners »

Rocket Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $43k 13k 3.26

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corp Stock (MSFT)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Alphabet Stock (GOOGL)
Alphabet Stock (GOOG)
Ishares Tr Etf (QUAL)
Meta Platforms Stock (META)

View all positions for HPM Partners

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Maverick Capital
BlackRock
Vanguard Group
MPM Oncology Impact Management
Suvretta Capital Management
Millennium Management
Morgan Stanley
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Two Sigma Advisers

View all funds holding Rocket Pharmaceuticals